Biodel Announces Commercial Supply Agreement With Becton, Dickinson
December 17, 2013 at 08:22 AM EST
Biodel. (Nasdaq: BIOD ) today announced a long-term supply agreement with BD (NYSE: BDX ) for worldwide exclusive rights to the novel and proprietary BD Uniject SCF™ Disposable Auto-Disable Injection System for the delivery of liquid glucagon to treat severe hypoglycemia. Financial terms of the agreement have not
